Another day of games and manipulation of WBT's share price on the ASX, in the absence of actual news from the company (so basically no reason for a drop in the SP related to the company's activities). It's now looking more oversold than ever.
Interesting take on the quarterly news in "tipranks" dated 28 Feb:
"Weebit Nano Reports Revenue Surge Amidst Strategic Licensing Milestones"
"Weebit Nano Ltd. reported a significant increase in revenue from ordinary activities by 341% for the half-year ended December 31, 2024, despite a 10% decrease in losses compared to the previous period. The company has accelerated its commercial activities through a licensing agreement with onsemi and has achieved key milestones in its DB HiTek license agreement. Looking ahead, Weebit Nano aims to secure new licensing and customer agreements in 2025, which could enhance its market position and stakeholder value."
All IMHO, DYOR
- Forums
- ASX - By Stock
- WBT
- Ann: Appendix 4D & FY25 Interim Financial Statements
WBT
weebit nano ltd
Add to My Watchlist
2.64%
!
$1.66

Ann: Appendix 4D & FY25 Interim Financial Statements, page-51
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
-0.045(2.64%) |
Mkt cap ! $340.2M |
Open | High | Low | Value | Volume |
$1.71 | $1.72 | $1.63 | $487.3K | 294.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1967 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 1811 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 377 | 1.660 |
9 | 3659 | 1.655 |
6 | 4957 | 1.650 |
5 | 3332 | 1.645 |
8 | 45376 | 1.640 |
Price($) | Vol. | No. |
---|---|---|
1.665 | 2849 | 5 |
1.670 | 3010 | 6 |
1.675 | 7322 | 6 |
1.680 | 24968 | 8 |
1.685 | 4888 | 5 |
Last trade - 12.27pm 30/06/2025 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online